Free Trial

Summit Therapeutics (SMMT) SEC Filings & 10K Form

Summit Therapeutics logo
$19.03 +0.84 (+4.62%)
As of 04:00 PM Eastern

Recent Summit Therapeutics SEC Filings

DateFilerForm TypeView
01/14/2025
3:06 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:37 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
6:49 PM
DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:24 PM
Summit Therapeutics (Issuer)
Xia Yu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:30 PM
Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:39 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:17 PM
Cesano Alessandra (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:57 PM
Booth Robert F. (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:05 PM
Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:11 PM
Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
6:33 AM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
6:06 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:08 PM
Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:54 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
4:28 PM
Summit Therapeutics (Filer)
Form S-3ASR
09/13/2024
6:29 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:25 PM
DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:54 PM
DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
Form SC 13D/A
09/13/2024
4:40 PM
Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:26 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:29 PM
Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
5:49 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
6:23 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:14 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:37 AM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/27/2024
4:20 PM
Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:16 PM
Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2024
3:27 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
4:14 PM
Summit Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
06/17/2024
4:25 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
1:03 PM
Summit Therapeutics (Filer)
Form DEFA14A
06/03/2024
5:18 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
5:05 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
3:48 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
7:35 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
7:03 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
6:48 AM
Summit Therapeutics (Filer)
Form 424B5
05/01/2024
7:45 AM
Summit Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/01/2024
7:18 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
7:11 AM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/15/2024
8:21 AM
Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
8:19 AM
Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/11/2024
3:35 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
4:52 PM
Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
4:43 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/04/2024
4:47 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
3:42 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
7:27 PM
Dhingra Ankur (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:28 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
7:07 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
7:36 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
11:15 PM
Summit Therapeutics (Filer)
Form EFFECT
02/20/2024
6:55 AM
Summit Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/20/2024
7:05 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
6:32 AM
Summit Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
4:25 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:35 PM
Summit Therapeutics (Issuer)
Xia Yu (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/08/2024
3:08 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SMMT) was last updated on 1/17/2025 by MarketBeat.com Staff
From Our Partners